Cladribine injection and Oxybutynin Extended-Release Tablets
Determining the interaction of Cladribine injection and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cladribine
Brand name: Mavenclad, Leustatin
Synonyms: Cladribine
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cladribine injection-Oxybutynin Gel
- Cladribine injection-Oxybutynin Oral Solution
- Cladribine injection-Oxybutynin Syrup
- Cladribine injection-Oxybutynin Tablets
- Cladribine injection-Oxybutynin transdermal
- Cladribine injection-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-Cladribine Intravenous
- Oxybutynin Extended-Release Tablets-Cladribine Tablets
- Oxybutynin Extended-Release Tablets-Claforan
- Oxybutynin Extended-Release Tablets-Claforan in D5W
- Oxybutynin Extended-Release Tablets-Claravis
- Oxybutynin Extended-Release Tablets-Clarifoam EF